Navigation Links
National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
Date:8/31/2013

ST. LOUIS (PRWEB) August 31, 2013

The national law firm Baron and Budd has begun outreach to help women allegedly injured by statin drugs, such as Lipitor, understand their legal options. Prescribed to lower cholesterol, Lipitor has recently come into question because of the drug's alleged risk of developing type 2 diabetes in female patients. (In re: Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)).

"Type 2 diabetes is a dangerous and life-long condition that increases the patient's risk for blindness, strokes, heart attacks and kidney disease,” said Russell Budd of Baron and Budd. “What's most concerning is that, according to court documents, some healthy women who begin taking Lipitor as part of a preventative measure to decrease their odds of developing heart disease are allegedly developing type 2 diabetes - a condition that puts patients at an increased risk for many serious issues."

In addition to the increased risk of blindness, stroke, heart attack and heart disease that comes with type 2 diabetes, patients who find themselves diagnosed with type 2 diabetes must also commit themselves to a strict diet and must routinely keep track of their blood sugar levels. (http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm)

By educating women who allegedly developed diabetes as a result of Lipitor use, Baron and Budd hopes to assist those harmed get back on their feet.

At this time, the Lipitor lawyers at Baron and Budd are reviewing claims involving women with a Body Mass Index (BMI) of 35 or under who developed diabetes while taking Lipitor. Anyone who is concerned may contact Baron and Budd for a free and confidential evaluation of their potential case. Please call the Lipitor lawsuit lawyers at 1.866.844.4556 or email them at info(at)baronbudd(dot)com. Learn more at the firm’s website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/lipitor-lawsuit.

The national plaintiffs' law firm of Baron and Budd is a leading national firm and has a dedicated team focused on dangerous drugs and medical devices. Baron and Budd was recently a finalist for the Public Justice 2013 Trial Lawyer of the Year Award. Lawyers at Baron and Budd have been nominated as finalists for the Trial Lawyer of the Year Award four times within the last six years.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11070969.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NewsWatch Featured “TapForMessage”, an NFC Enabled Video Greeting, on National Television
2. Malibu Senior Center Invites Resource Speakers for the National Falls Prevention Awareness Day
3. Mercy College Awarded Grant from the National Science Foundation to Expand STEM Programs
4. Luciana Lagana and Gregory Graham’s Feature Screenplay “Old River Road” Wins ‘Best Dramatic Screenplay’ at the 2013 AOF International Film Festival
5. Pretty Mommies Announces a National Sales Campaign with UBS Aesthetics
6. Aeromedevac International Air Ambulance and Medical Flight Company Soars with Service Around the World
7. Miracle-Ear Launches Revamped National Website
8. Report Released By the National Academy of Social Insurance This Month Shows Georgia To Be One of 22 States Whose Workers’ Compensation Benefits Payments Dropped in 2011
9. 2nd Annual Brains Matter Conference Brings Together National Brain Tumor Experts to the Pacific Northwest
10. Humpty Dumpty Day School is The First Educational First Steps Assisted Center to Reach National Accreditation in Tarrant County
11. Voyance Announces 2012/2013 National APEX Quality Award Winners for Healthcare Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 ... the only option for on-premises installation of its Help System for SharePoint was at ... the system into the entire tenant. , The company recently released a modified ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
(Date:3/28/2017)... NEW YORK, NEW YORK (PRWEB) , ... March ... ... their breakthrough development, NTX Technology™, is the first technology to directly address the ... World Health Organization. NTX Technology™ is a patented compound of FDA and TTB ...
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... Market Outlook: 2016-2022" report to their offering. ... The global patient safety and ... delivery, end-user, and geography. Patient safety has become ... The field has developed significantly in the last decade and is ...
(Date:3/28/2017)... , March 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – ... the disease and global market trends of the Chemotherapy Induced Neutropenia ... , Europe ( France , ... Spain , UK) and Japan , ... and rest of the world (RoW). The Report covers ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: